GlassScriptPhysician profile
Tyler Stoots
NPI 1548682941
$2,203.06
in general payments reported to CMS, 2019-2025
15 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,108 · 2022: $747 · 2023: $24.26 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $645.20 | 2021-2022 | |
| Glaxosmithkline, LLC. | $494.92 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $297.76 | 2021-2025 | Airsupra |
| Novo Nordisk INC | $137.06 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $108.90 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $100.00 | 2021 | |
| Lilly USA, LLC | $82.16 | 2021 | |
| Abbvie INC. | $81.04 | 2022-2023 | |
| Abiomed | $59.86 | 2025 | |
| Amgen INC. | $44.37 | 2021 | |
| Pfizer INC. | $44.26 | 2021 | |
| Janssen Scientific Affairs, LLC | $41.81 | 2022 | |
| Clarus Therapeutics INC. | $28.55 | 2021 | |
| Genentech USA, INC. | $23.94 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Stoots listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.